{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,14]],"date-time":"2025-10-14T00:08:50Z","timestamp":1760400530239,"version":"build-2065373602"},"reference-count":24,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,11,22]],"date-time":"2023-11-22T00:00:00Z","timestamp":1700611200000},"content-version":"vor","delay-in-days":965,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Research in Microbiology"],"published-print":{"date-parts":[[2021,4]]},"DOI":"10.1016\/j.resmic.2021.103816","type":"journal-article","created":{"date-parts":[[2021,3,18]],"date-time":"2021-03-18T09:31:56Z","timestamp":1616059916000},"page":"103816","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["Performance of the GenoType MTBDRsl V 2.0 for detecting second-line drugs resistance of Mycobacterium tuberculosis isolates in Tunisia"],"prefix":"10.1016","volume":"172","author":[{"given":"Imen","family":"Bouzouita","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Henda","family":"Draoui","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9727-6465","authenticated-orcid":false,"given":"Andrea Maurizio","family":"Cabibbe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Leila","family":"Essalah","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sana","family":"Bejaoui","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alberto","family":"Trovato","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F\u00e9ri\u00e8le","family":"Messadi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniela Maria","family":"Cirillo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Leila","family":"Slim-Saidi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"year":"2020","series-title":"Global Tuberculosis Report 2020","author":"World Health Organization","key":"10.1016\/j.resmic.2021.103816_bib1"},{"author":"World Health Organization: regional office for the Eastern Mediterrnean","key":"10.1016\/j.resmic.2021.103816_bib2"},{"year":"2019","series-title":"WHO Consolidated Guidelines on Drug-Resistant Tuberculosis Treatment","author":"World Health Organization","key":"10.1016\/j.resmic.2021.103816_bib3"},{"key":"10.1016\/j.resmic.2021.103816_bib4","doi-asserted-by":"crossref","first-page":"1573","DOI":"10.1128\/JCM.00051-16","article-title":"Performance of the new version (v2.0) of the GenoType MTBDRsl test for detection of resistance to second-line drugs in multidrug-resistant Mycobacterium tuberculosis complex strains","volume":"54","author":"Brossier","year":"2016","journal-title":"J\u00a0Clin Microbiol"},{"year":"2016","series-title":"The Use of Molecular Line Probe Assays for the Detection of Resistance to Second-Line Anti-tuberculosis Drugs: Policy Guidance","author":"World Health Organization","key":"10.1016\/j.resmic.2021.103816_bib5"},{"year":"2012","series-title":"Updated Interim Critical Concentrations for First-Line and Second-Line DST","author":"World Health Organization","key":"10.1016\/j.resmic.2021.103816_bib6"},{"year":"2018","series-title":"Technical Report on Critical Concentrations for Drug Susceptibility Testing of Medicines Used in the Treatment of Drug-Resistant Tuberculosis","author":"World Health Organization","key":"10.1016\/j.resmic.2021.103816_bib7"},{"year":"2015","series-title":"Molecular genetic assay for identification of the M.\u00a0tuberculosis complex and its resistance to fluoroquinolones and aminoglycosides\/cyclic peptides from sputum specimens or cultivated samples","author":"GenoType MTBDRsl assay VER2.0","key":"10.1016\/j.resmic.2021.103816_bib8"},{"key":"10.1016\/j.resmic.2021.103816_bib9","doi-asserted-by":"crossref","first-page":"547","DOI":"10.3201\/eid2503.181370","article-title":"Whole \u2013genome sequencing of drug-resistant Mycobacterium tuberculosis strains, Tunisia 2012-2016","volume":"25","author":"Bouzouita","year":"2019","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.resmic.2021.103816_bib10","doi-asserted-by":"crossref","first-page":"1908","DOI":"10.1128\/JCM.00025-15","article-title":"PhyResSe: a web Tool Delineating Mycobacterium tuberculosis antibiotic resistance and lineage from whole-genome sequencing data","volume":"53","author":"Feuerriegel","year":"2015","journal-title":"J\u00a0Clin Microbiol"},{"year":"2013","series-title":"OpenEpi: Open Source Epidemiologic Statistics for Public Health","author":"Dean","key":"10.1016\/j.resmic.2021.103816_bib11"},{"key":"10.1016\/j.resmic.2021.103816_bib12","doi-asserted-by":"crossref","first-page":"2967","DOI":"10.1099\/00221287-148-10-2967","article-title":"Re-annotation of the genome sequence of Mycobacterium tuberculosis H37Rv","volume":"148","author":"Camus","year":"2002","journal-title":"Microbiology"},{"key":"10.1016\/j.resmic.2021.103816_bib13","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1038\/31159","article-title":"Deciphering the biology of Mycobacterium tuberculosis from the complete genome sequence","volume":"393","author":"Cole","year":"1998","journal-title":"Nature"},{"key":"10.1016\/j.resmic.2021.103816_bib14","doi-asserted-by":"crossref","first-page":"2961","DOI":"10.1128\/JCM.01257-15","article-title":"Diagnostic performance of the new version (v2.0) of GenoType MTBDRsl assay for detection of resistance to fluoroquinolones and second-line injectable drugs: a multicenter study","volume":"53","author":"Tagliani","year":"2015","journal-title":"J\u00a0Clin Microbiol"},{"key":"10.1016\/j.resmic.2021.103816_bib15","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1093\/jac\/dkr566","article-title":"A\u00a0systematic review of gyrase mutations associated with fluoroquinolone-resistant Mycobacterium tuberculosis and a proposed gyrase numbering system","volume":"67","author":"Maruri","year":"2012","journal-title":"J\u00a0Antimicrob Chemother"},{"key":"10.1016\/j.resmic.2021.103816_bib16","doi-asserted-by":"crossref","first-page":"1701354","DOI":"10.1183\/13993003.01354-2017","article-title":"A\u00a0standardised method for interpreting the association between mutations and phenotypic drug resistance in Mycobacterium tuberculosis","volume":"50","author":"Miotto","year":"2017","journal-title":"Eur Respir J"},{"author":"Global laboratory initiative advancing TB diagnosis","key":"10.1016\/j.resmic.2021.103816_bib17"},{"key":"10.1016\/j.resmic.2021.103816_bib18","doi-asserted-by":"crossref","first-page":"20005","DOI":"10.1073\/pnas.0907925106","article-title":"Overexpression of the chromosomally encoded aminoglycoside acetyltransferase eis confers kanamycin resistance in Mycobacterium tuberculosis","volume":"106","author":"Zaunbrecher","year":"2009","journal-title":"PNAS"},{"year":"2019","series-title":"Global Tuberculosis Report 2019","author":"World Health Organization","key":"10.1016\/j.resmic.2021.103816_bib19"},{"key":"10.1016\/j.resmic.2021.103816_bib20","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1128\/JCM.01865-16","article-title":"Evaluation of the GenoType MTBDRsl Version 2.0 assay second-line drug resistance detection of Mycobacterium tuberculosis isolates in South Africa","volume":"55","author":"Gardee","year":"2017","journal-title":"J\u00a0Clin Microbiol"},{"key":"10.1016\/j.resmic.2021.103816_bib21","doi-asserted-by":"crossref","first-page":"419","DOI":"10.5588\/ijtld.17.0663","article-title":"Diagnostic accuracy of GenoType MTBDRsl VER 2.0 in detecting second-line drug resistance to M.\u00a0tuberculosis","volume":"22","author":"Yadav","year":"2018","journal-title":"Int J Tuberc Lung dis"},{"key":"10.1016\/j.resmic.2021.103816_bib22","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.diagmicrobio.2016.08.026","article-title":"Performance of the GenoType MTBDRplus assay (v2.0) and a new extended GenoType MTBDRsl assay (v2.0) for the molecular detection of multi- and extensively drug-resistant Mycobacterium tuberculosis on isolates primarily from Lithuania","volume":"86","author":"Bang","year":"2016","journal-title":"Diag Microbiol Infect Dis"},{"key":"10.1016\/j.resmic.2021.103816_bib23","doi-asserted-by":"crossref","first-page":"957","DOI":"10.3201\/eid1106.041365","article-title":"Tuberculosis due to resistant Haarlem strain, Tunisia","volume":"11","author":"Mardassi","year":"2005","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.resmic.2021.103816_bib24","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1099\/jmm.0.47483-0","article-title":"Genetic profiling of Mycobacterium tuberculosis in Tunisia : predominance and evidence for the establishment of a new genotypes","volume":"57","author":"Namouchi","year":"2008","journal-title":"J\u00a0Med Microbiol"}],"container-title":["Research in Microbiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0923250821000309?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0923250821000309?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,13]],"date-time":"2025-10-13T05:16:31Z","timestamp":1760332591000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0923250821000309"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,4]]},"references-count":24,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2021,4]]}},"alternative-id":["S0923250821000309"],"URL":"https:\/\/doi.org\/10.1016\/j.resmic.2021.103816","relation":{},"ISSN":["0923-2508"],"issn-type":[{"type":"print","value":"0923-2508"}],"subject":[],"published":{"date-parts":[[2021,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Performance of the GenoType MTBDRsl V 2.0 for detecting second-line drugs resistance of Mycobacterium tuberculosis isolates in Tunisia","name":"articletitle","label":"Article Title"},{"value":"Research in Microbiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.resmic.2021.103816","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Institut Pasteur. Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"103816"}}